Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Schreier, US
Harold J. Schreier, Baltimore, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20120152176 | MICROBIAL MEDIATED CHEMICAL SEQUESTERING OF PHOSPHATE IN A CLOSED-LOOP RECIRCULATING AQUACULTURE SYSTEM - A system and method for removal of phosphates from a closed loop estuarine or marine recirculating aquaculture system (RAS), involving denitrification in the presence of a media substrate for: 1) anaerobic nitrate, nitrite and ammonia removal and 2) sequestering of excess phosphate in the RAS. Phosphate is precipitated in or on the denitrifying biofilm formed on the media substrate as phosphate salts. The phosphate salt-containing media substrate can be removed from the RAS, the phosphates can be removed, and both the substrate and the phosphates can be reused or recycled. | 06-21-2012 |
John Schreier, Red Hill, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20080262046 | Amidopropoxyphenyl Orexin Receptor Antagonists - The present invention is directed to amidopropoxyphenyl compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved. | 10-23-2008 |
John D. Schreier, Lindstrom, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20080283326 | Drivetrain for an all terrain vehicle - An all-terrain vehicle including a frame having longitudinally-spaced ends defining a first longitudinal axis, and an engine supported by the frame. The engine includes a crankshaft defining a second longitudinal axis substantially parallel to the first longitudinal axis. | 11-20-2008 |
| 20080283327 | Frame for an all terrain vehicle - An all-terrain vehicle including a frame having longitudinally-spaced ends defining a first longitudinal axis, and an engine supported by the frame. The engine includes a crankshaft defining a second longitudinal axis substantially parallel to the first longitudinal axis. | 11-20-2008 |
| 20120137828 | VEHICLE AND TRANSMISSION FOR A VEHICLE - A vehicle is described having a transmission driven through a propulsion unit such as an engine, and through a CVT. The transmission is comprised of an input shaft and an output shaft which are coaxially disposed. An idler shaft is driven by the input shaft, and the idler shaft drives the output shaft, through selected gear sets, to provide different gear ratios or drive directions. The CVT also has a fan on the driven side which feeds air through the CVT for cooling. The CVT comprises a drive side clutch and a driven side clutch with the output shaft of the extending through the CVT driven clutch. | 06-07-2012 |
John D. Schreier, Linstrom, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20110073403 | DRIVETRAIN FOR AN ALL TERRAIN VEHICLE - An all-terrain vehicle including a frame having longitudinally-spaced ends defining a first longitudinal axis, and an engine supported by the frame. The engine includes a crankshaft defining a second longitudinal axis substantially parallel to the first longitudinal axis. | 03-31-2011 |
John D. Schreier, Red Hill, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090105318 | Amidoethylthioether Orexin Receptor Antagonists - The present invention is directed to amidoethylthioether compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved. | 04-23-2009 |
| 20100168134 | PYRIDYL PIPERIDINE OREXIN RECEPTOR ANTAGONISTS - The present invention is. directed to pyridyl piperidine compounds of formula (I) which are antagonists of orexin receptors, and which are useful' in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved. | 07-01-2010 |
John D. Schreier, Harleysville, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110251237 | 2,5-Disubstituted Piperidine Orexin Receptor Antagonists - The present invention is directed to 2,5-disubstituted piperidine amide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved. | 10-13-2011 |
| 20120065211 | ALKOXY TETRAHYDRO-PYRIDOPYRIMIDINE PDE10 INHIBITORS - The present invention is directed to alkoxy tetrahydro-pyridopyrimidine compounds which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction. | 03-15-2012 |
John D. Schreier, Philadephia, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110263643 | 2,3-Disubstituted Piperidine Orexin Receptor Antagonists - The present invention is directed to 2,3-disubstituted piperidine amide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved. | 10-27-2011 |
John D. Schreier, Philadalphia, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20120136012 | AMINO TETRAHYDRO-PYRIDOPYRIMIDINE PDE10 INHIBITORS - The present invention is directed to amino tetrahydro-pyridopyrimidine compounds which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction. | 05-31-2012 |
John D. Schreier, Philadelphia, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110201632 | 2,5-Disubstituted Piperidine Orexin Rceptor Antagonists - The present invention is directed to 2,5-disubstituted piperidine amide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved. | 08-18-2011 |
| 20110201652 | 2,4-Disubstituted Pyrrolidine Orexin Receptor Antagonists - The present invention is directed to 2,4-disubstituted pyrrolidine amide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved. | 08-18-2011 |
| 20110207715 | Disubstituted Azepan Orexin Receptor Antagonists - The present invention is directed to disubstituted azepan and oxazepan amide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved. | 08-25-2011 |
| 20110207747 | 2,5-Disubstituted Phenyl Carboxamide Orexin Receptor Antagonists - The present invention is directed to 2,5-disubstituted phenyl carboxamide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved. | 08-25-2011 |
| 20110312961 | 2,5-Disubstituted Morpholine Orexin REceptor Antagonists - The present invention relates to compounds that bind to and modulate the activity of neuronal nicotinic acetylcholine receptors, to processes for preparing these compounds, to pharmaceutical compositions containing these compounds, and to methods of using these compounds for treating a wide variety of conditions and disorders, including those associated with dysfunction of the central nervous system (CNS). | 12-22-2011 |
| 20120046289 | Pyridazine Carboxamide Orexin Receptor Antagonists - The present invention is directed to pyridazine carboxamide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved. | 02-23-2012 |
Marc R. Schreier, Romeoville, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20110136655 | Process and System for the Transfer of a Metal Catalyst Component from One Particle to Another - One exemplary embodiment can be a process for facilitating a transfer of a metal catalyst component from at least one donor particle to at least one recipient particle in a catalytic naphtha reforming unit. The process can include transferring an effective amount of the metal catalyst component from the at least one donor particle to the at least one recipient particle under conditions to effect such transfer to improve a conversion of a hydrocarbon feed. | 06-09-2011 |
Marc R. Schreier, Northbrook, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20090261018 | PROCESS AND SYSTEM FOR THE TRANSFER OF A METAL CATALYST COMPONENT FROM ONE PARTICLE TO ANOTHER - One exemplary embodiment can be a process for facilitating a transfer of a metal catalyst component from at least one donor particle to at least one recipient particle in a catalytic naphtha reforming unit. The process can include transferring an effective amount of the metal catalyst component from the at least one donor particle to the at least one recipient particle under conditions to effect such transfer to improve a conversion of a hydrocarbon feed. | 10-22-2009 |
| 20100116714 | Process and System for the Addition of Promoter Metal In Situ in a Catalytic Reforming Unit - One exemplary embodiment can be a process for facilitating adding a promoter metal to at least one catalyst particle in situ in a catalytic naphtha reforming unit. The process can include introducing a compound comprising the promoter metal to the catalyst naphtha reforming unit and adding an effective amount of the promoter metal from the compound comprising the promoter metal to the catalyst particle under conditions to effect such addition and improve a conversion of a hydrocarbon feed. | 05-13-2010 |
Steffen Schreier, Duvall, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20090271776 | DYNAMIC MANAGEMENT OF OPERATING SYSTEM RESOURCES - A method for dynamically managing operating system resources of a computing device. Each of the operating system resources have one or more data elements. The method includes: at an observer module of the operating system, monitoring stability and/or usage of the one or more data elements of each of the operating system resources, selecting an unused and/or unstable operating system resource data element; and removing a selected operating system resource data element. | 10-29-2009 |